Trial intelligence / Profile preview

Correlation Between Gene Expression, Catch-up Growth and Response to Saizen in Small for Gestational Age Children

2015-001681-25Phase 3

Sponsor
Merck KGaA
Start
Jul 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, open-label trial in Small for gestational age (SGA) comparing Saizen treatment arm with Untreated observation arm (2 arms). Primary endpoint: Correlation Between Gene Expression Profiling and Catch-up Growth.

02

Drugs

somatropin
03

Conditions

Small for gestational age (SGA)

Beyond the preview

Go deeper on 2015-001681-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001681-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call